Apr 12, 2021 10:25 AM IST
Multi-year opportunity awaits Indian vaccine manufacturers such as DRL, Gland Pharma, Aurobindo Pharma and Cadila Pharma
- Feb 15, 2021 04:01 PM IST
Covishield is the brand name for the AstraZeneca-Oxford University COVID-19 vaccine. Prime Minister Narendra Modi on February 10 had assured his Canadian counterpart Justin Trudeau that India would do its best to facilitate supplies of COVID vaccines sought by Canada.
- Jan 07, 2021 08:59 AM IST
The unseemly hurry to hand out approvals without adequate data in at least one case has long term implications for the Indian vaccine industry’s reputation
- Nov 26, 2020 10:53 AM IST
As things stand, the COVID-19 vaccination programme will be an enormous national project. An acceleration of the timetable may turn out to be the biggest effort the Indian State has made in its history
- Aug 04, 2020 11:05 AM IST
In a tweet on August 2, Mahindra had joked about a vaccine called "Big V", a reference to the Amitabh Bachchan's popular nickname "Big B" and how all of India needs a dose of that.
- Jun 26, 2020 04:39 PM IST
Investment banks Goldman Sachs, Citi and Avendus Capital have been engaged as advisors for the process by the privately held vaccine manufacturer, say sources.
- Jul 05, 2018 02:10 PM IST
Adar Poonawala took over from his father Cyrus, to guide the fortunes of the group. In an exclusive interview, he spoke about some of the group’s initiatives.
- Jan 21, 2017 02:51 PM IST
Adar Poonawala, CEO of Serum Institute, believes that a bigger partnership with Cipla will create a big Indian conglomerate. However, he added that the Cipla promoters currently have no plans for a merger and acquisition.
- Jan 07, 2016 08:52 PM IST
Serum Institute CEO Adar Poonawala has told CNBC-TV18 that Cipla and Serum will not be merging anytime soon. Cipla and Serum Institute have joined hands to sell products jointly across various countries in the world.